The Molecular Detection Core (MDC) is designed to fill an unmet need in the UAB neuroscience community for sensitive, automated immunohistochemistry (IHC) and in situ hybridization (ISH) detection. The centerpiece of the facility will be a Ventana Discovery1 System capable of fully automated IHC and ISH applications. This system, combined with well-trained technical support staff, will produce unparaheled high-throughput, reproducible, molecular localization results for both novice and experienced IHC/ISH investigators. The Discovery System is the only commercially-available automated detection instrument capable of ISH and multi-label localization procedures and the MDC will be the first facility of any type at UAB with these capabilities. The MDC will offer both conventional and ultrasensitive Tyramide Signal Amplification-Plus (TSA -Plus) detection procedures developed by Dr. Kevin A. Roth, core director, in collaboration with scientists at Perkin-Elmer Life Sciences. A novel procedure for sensitive and photostable immunofluorescence detection using combined TSA and quantum dot labeling, recently developed by Dr. Roth's laboratory, will also be available. The MDC will also offer both chromogenic and fluorescent detection options as well as perform multi-labeling IHC and ISH procedures. For inexperienced users, MDC personnel will assist investigators in determining optimal fixation conditions, tissue processing techniques, and experimental designs for detection of nervous system-associated molecules of interest. For experienced IHC/ISH investigators, the MDC will provide consistent, high quality labeled samples and assist in the development and implementation of novel detection procedures. The MDC will maintain a website where protocols can be accessed, images shared, and questions asked of other core users. An annual mini-symposium will be sponsored for investigators to present their results to other core users and to help facilitate collaborative research efforts. The overall goal of this core is to provide NINDS supported investigators, and other UAB neuroscience investigators, with state of the art molecular detection techniques so as to more effectively and efficiently achieve their research objectives. We expect the MDC to be an important bridge between pre-existing UAB campus facilities. Thus, we will receive specimen input from any of several tissue processing core laboratories and produce IHC/ISH labeled slides that can be visualized at any of several imaging facilities (both standard and confocal microscopy facilities are readily available). Alternatively, investigators may submit cell and/or tissue sections prepared in their own laboratory or with MDC-associated tissue processing equipment for IHC/ISH labeling with subsequent visualization performed using microscopes available in the MDC or in their own laboratories. This large degree of experimental flexibility will permit each investigator to """"""""customize"""""""" their MDC usage to best meet their individual needs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
1P30NS047466-01A2
Application #
7090250
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2005-07-01
Project End
2010-05-31
Budget Start
2005-07-01
Budget End
2006-05-31
Support Year
1
Fiscal Year
2005
Total Cost
$203,583
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wadsworth, Heather M; Maximo, Jose O; Donnelly, Rebecca J et al. (2018) Action simulation and mirroring in children with autism spectrum disorders. Behav Brain Res 341:1-8
McMeekin, Laura J; Li, Ye; Fox, Stephanie N et al. (2018) Cell-Specific Deletion of PGC-1? from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment. J Neurosci 38:3273-3286
Harms, Ashley S; Thome, Aaron D; Yan, Zhaoqi et al. (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179-187
Wang, Bing; Underwood, Rachel; Kamath, Anjali et al. (2018) 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic ?-Synuclein. J Neurosci 38:8211-8232
Rangarajan, Sunad; Bone, Nathaniel B; Zmijewska, Anna A et al. (2018) Metformin reverses established lung fibrosis in a bleomycin model. Nat Med 24:1121-1127
Arrant, Andrew E; Filiano, Anthony J; Patel, Aashka R et al. (2018) Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Neurobiol Dis 124:152-162
Ramani, Manimaran; Kumar, Ranjit; Halloran, Brian et al. (2018) Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Pathways Required for Learning and Memory. Sci Rep 8:9914
Bohannon, Andrew S; Hablitz, John J (2018) Developmental Changes in HCN Channel Modulation of Neocortical Layer 1 Interneurons. Front Cell Neurosci 12:20
Larson-Casey, Jennifer L; Gu, Linlin; Jackson, Patricia L et al. (2018) Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke-induced Pneumonia. Am J Respir Crit Care Med 198:1288-1301
Arrant, Andrew E; Nicholson, Alexandra M; Zhou, Xiaolai et al. (2018) Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Mol Neurodegener 13:32

Showing the most recent 10 out of 207 publications